Treatment of Post-Stroke Pain
For post-stroke pain management, a stepwise pharmacological approach starting with amitriptyline or lamotrigine as first-line treatments, followed by pregabalin or gabapentin as second-line options, and opioids as third-line therapy is recommended, combined with appropriate non-pharmacological interventions. 1
Types of Post-Stroke Pain
Central Post-Stroke Pain (CPSP):
- Affects 2-8% of stroke patients
- Characterized by burning or aching sensations, often with allodynia
- Located in areas corresponding to brain lesion 2
Hemiplegic Shoulder/Neck Pain:
- Related to subluxation, spasticity, or soft tissue injury
- May have both musculoskeletal and neuropathic components 2
Musculoskeletal Pain:
- Often related to spasticity, positioning issues, or compensatory movements 1
Pharmacological Management Algorithm
First-Line Treatments:
- Anticonvulsants: Lamotrigine (effective for reducing daily pain, though only 44% of patients have good response) 1, 2
- Tricyclic Antidepressants: Amitriptyline 75mg at bedtime (shown to lower pain ratings and improve function) 1
Second-Line Treatments:
- Other Anticonvulsants: Pregabalin or gabapentin (effective for neuropathic pain components) 1
- SNRIs: Particularly duloxetine 1
Third-Line Treatments:
- Opioids or tramadol (for resistant cases, with caution due to dependency risk) 1
- Carbamazepine or phenytoin (limited evidence but may be considered) 1
Management of Spasticity-Related Pain
Non-pharmacological approaches:
- Antispastic positioning
- Range of motion exercises
- Stretching
- Splinting or serial casting 1
Pharmacological options:
Interventional options (for severe cases):
Advanced Interventions for Refractory Central Pain
- Motor cortex stimulation: May be reasonable for intractable central post-stroke pain, with >50% pain reduction in 50-83% of patients, though associated with complications including infection, hardware failure, and seizures 1, 2
- TENS: Not established as effective for central post-stroke pain 1
- Deep brain stimulation: Not recommended due to conflicting evidence 1, 2
Monitoring Treatment Response
- Use standardized serial measurements such as:
- Pain diaries
- Visual analog scales
- Pain questionnaires 1
Important Clinical Considerations
- Pain after stroke is often undertreated but significantly impacts recovery and quality of life 3
- Gabapentin has shown promise in treating thalamic pain syndrome (a type of CPSP) in recent studies 4
- The choice of medication should consider the patient's comorbidities, potential side effects, and drug interactions 5
- Stroke patients often have multiple pain locations, with head, leg, back, and shoulder being most common 6
By following this structured approach to post-stroke pain management, clinicians can effectively address this challenging complication and improve patients' functional outcomes and quality of life.